Synthesis and activity of N-acyl azacyclic urea HIV-1 protease inhibitors with high potency against multiple drug resistant viral strains
Zhao, C., Sham, H.L., Sun, M., Stoll, V.S., Stewart, K.D., Lin, S., Mo, H., Vasavanonda, S., Saldivar, A., Park, C., McDonald, E.J., Marsh, K.C., Klein, L.L., Kempf, D.J., Norbeck, D.W.(2005) Bioorg Med Chem Lett 15: 5499-5503
- PubMed: 16203141 
- DOI: https://doi.org/10.1016/j.bmcl.2005.08.093
- Primary Citation of Related Structures:  
2A4F - PubMed Abstract: 
As part of our efforts to identify potent HIV-1 protease inhibitors that are active against resistant viral strains, structural modification of the azacyclic urea (I) was undertaken by incorporating acyl groups as P(1)' ligands. The extensive SAR study has yielded a series of N-acyl azacyclic ureas (II), which are highly potent against both wild-type and multiple PI-resistant viral strains.
Organizational Affiliation: 
GPRD, Abbott Laboratories, Abbott Park, IL 60064-6123, USA. chen.zhao@abbott.com